International Impact of COVID-19 on the Diagnosis of Heart Disease

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Andrew J Einstein, New York-Presbyterian Hospital/Columbia University Irving Medical Center
  • ,
  • Leslee J Shaw, Weill Cornell Medical College/NewYork-Presbyterian Hospital
  • ,
  • Cole Hirschfeld, New York-Presbyterian Hospital/Columbia University Irving Medical Center
  • ,
  • Michelle C Williams, Edinburgh University, Edinburgh
  • ,
  • Todd C Villines, Virginia Commonwealth University, Virginia
  • ,
  • Nathan Better, University of Melbourne
  • ,
  • Joao V Vitola, Quanta Diagnostico
  • ,
  • Rodrigo Cerci, Quanta Diagnostico
  • ,
  • Sharmila Dorbala, Brigham and Women’s Hospital, Boston, MA
  • ,
  • Paolo Raggi, Univ Alberta, University of Alberta, Dept Psychiat
  • ,
  • Andrew D Choi, The George Washington University School of Medicine, Washington, DC, USA.
  • ,
  • Bin Lu, Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China.
  • ,
  • Valentin Sinitsyn, Lomonosov Moscow State University
  • ,
  • Vladimir Sergienko, National Medical Research Center of Cardiology of Healthcare Ministry
  • ,
  • Takashi Kudo, Nagasaki University
  • ,
  • Bjarne Linde Nørgaard
  • ,
  • Pál Maurovich-Horvat, Semmelweis University
  • ,
  • Roxana Campisi, Diagnóstico Maipú
  • ,
  • Elisa Milan, Ospedale Regionale di Treviso "S.Maria di Cà Foncello", Treviso, Italy.
  • ,
  • Lizette Louw, Donald Gordon Medical Centre
  • ,
  • Adel H Allam, Al-Azhar University
  • ,
  • Mona Bhatia, Fortis Escorts Heart Institute
  • ,
  • Eli Malkovskiy, Columbia University in the City of New York, New York Presbyterian Hospital
  • ,
  • Benjamin Goebel, Weill Cornell Medical College/NewYork-Presbyterian Hospital
  • ,
  • Yosef Cohen, Technion-Israel Institute of Technology
  • ,
  • Michael Randazzo, New York-Presbyterian Hospital/Columbia University Irving Medical Center
  • ,
  • Jagat Narula, Mount Sinai Medical Center
  • ,
  • Thomas N B Pascual, Philippines Nuclear Research Institute
  • ,
  • Yaroslav Pynda, International Atomic Energy Agency
  • ,
  • Maurizio Dondi, International Atomic Energy Agency
  • ,
  • Diana Paez, International Atomic Energy Agency
  • ,
  • INCAPS COVID Investigators Group

Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted.

OriginalsprogEngelsk
TidsskriftJournal of the American College of Cardiology
Vol/bind77
Nummer2
Sider (fra-til)173-185
Antal sider13
ISSN0735-1097
DOI
StatusUdgivet - jan. 2021

Se relationer på Aarhus Universitet Citationsformater

ID: 208364112